Literature DB >> 11059812

How many endobains are there?

G Rodríguez de Lores Arnaiz1.   

Abstract

Oxidative metabolism is very active in brain, where large amounts of chemical energy as ATP molecules are consumed, mostly required to maintain cellular Na+/K+ gradients through the participation of the sodium pump (Na+,K+-ATPase), whose activity is selectively and potently inhibited by the alkaloid ouabain. Na+/K+ gradients are involved in nerve impulse propagation, in neurotransmitter release and cation homeostasis in the nervous system. Likewise, enzyme activity modulation is crucial for maintaining normal blood pressure and cardiovascular contractility as well as renal sodium excretion. The present article reviews the progress in disclosing putative ouabain-like substances, examines their denomination according to different research teams, tissue or biological fluid sources, extraction and purification, assays, biological properties and chemical and biophysical features. When data is available, comparison with ouabain itself is mentioned. Likewise, their potential action in normal physiology as well as in experimental and human pathology is summarized.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11059812     DOI: 10.1023/a:1007620918408

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  103 in total

1.  Identification and characterization of a ouabain-like compound from human plasma.

Authors:  J M Hamlyn; M P Blaustein; S Bova; D W DuCharme; D W Harris; F Mandel; W R Mathews; J H Ludens
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 2.  Role of endogenous brain "ouabain" in the sympathoexcitatory and pressor effects of sodium.

Authors:  J W Van Huysse; F H Leenen
Journal:  Clin Exp Hypertens       Date:  1998 Jul-Aug       Impact factor: 1.749

Review 3.  Isozymes of the Na+/K+-ATPase.

Authors:  K J Sweadner
Journal:  Biochim Biophys Acta       Date:  1989-05-09

4.  Regulation of (Na+, K+) adenosinetriphosphatase of nerve ending membranes: action of norepinephrine and a soluble factor.

Authors:  G Rodriguez De Lores Arnaiz; M Mistrorigo De Pacheco
Journal:  Neurochem Res       Date:  1978-12       Impact factor: 3.996

5.  Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.

Authors:  M B Pamnani; B T Swindall; J F Schooley; R Ghai; F J Haddy
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1999-02       Impact factor: 1.770

6.  Partial purification and properties of the inhibitors of Na, K-ATPase and ouabain-binding in bovine central nervous system.

Authors:  K Akagawa; N Hara; Y Tsukada
Journal:  J Neurochem       Date:  1984-03       Impact factor: 5.372

7.  Diuretic and natriuretic effect of a brain soluble fraction that inhibits neuronal Na+,K(+)-ATPase.

Authors:  S Nowicki; M A Enero; G Rodriguez de Lores Arnaiz
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

8.  Isolation and characterization of a sodium pump inhibitor from human plasma.

Authors:  J M Hamlyn; D W Harris; M A Clark; A C Rogowski; R J White; J H Ludens
Journal:  Hypertension       Date:  1989-06       Impact factor: 10.190

9.  Effects of dietary sodium on central and peripheral ouabain-like activity in spontaneously hypertensive rats.

Authors:  F H Leenen; E Harmsen; H Yu; C Ou
Journal:  Am J Physiol       Date:  1993-06

10.  An endogenous factor which interacts with synaptosomal membrane Na+, K(+)-ATPase activation by K+.

Authors:  G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  1993-06       Impact factor: 3.996

View more
  12 in total

1.  A comparative study between a brain Na+,K(+)-ATPase inhibitor (endobain E) and ascorbic acid.

Authors:  G Rodríguez de Lores Arnaiz; T Herbin; C Peña
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

2.  Changes in Na+, K+-ATPase activity and alpha 3 subunit expression in CNS after administration of Na+, K+-ATPase inhibitors.

Authors:  María Geraldina Bersier; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2010-11-16       Impact factor: 3.996

3.  Repeated electroconvulsive shock induces changes in high-affinity [3H]-ouabain binding to rat striatal membranes.

Authors:  Magda Bignotto; Marco Antonio Campana Benedito
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

4.  The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na+, K+-ATPase inhibitor.

Authors:  María Geraldina Bersier; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2007-08-08       Impact factor: 3.996

5.  Inhibition of ATPases enzyme activities on brain disturbing normal oestrous cycle.

Authors:  J Venugopal; S Ramakrishna
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

6.  An endogenous Na+, K+-ATPase inhibitor enhances phosphoinositide hydrolysis in neonatal but not in adult rat brain cortex.

Authors:  M A Calviño; C Peña; G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2001-11       Impact factor: 3.996

7.  Modulation of aspartate release by ascorbic acid and endobain E, an endogenous Na+, K+ -ATPase inhibitor.

Authors:  M G Bersier; V Miksztowicz; C Peña; G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

8.  Intracerebroventricular administration of ouabain to rats changes the expression of NMDA receptor subunits in cerebral cortex and hippocampus.

Authors:  María Geraldina Bersier; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2009-03-26       Impact factor: 3.996

9.  Neurotensin effect on Na+, K+-ATPase is CNS area- and membrane-dependent and involves high affinity NT1 receptor.

Authors:  María Graciela López Ordieres; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

10.  High-affinity neurotensin receptor is involved in phosphoinositide turnover increase by inhibition of sodium pump in neonatal rat brain.

Authors:  Susana Pereyra-Alfonso; María Del Valle Armanino; Carolina Vázquez; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2008-08-29       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.